Publications
- PHOSPHATIDYLSERINE-DEPENDENT ANTI-PROTHROMBIN (APS/PT) ANTIBODIES AND ANTIPHOSPHOLIPID (APL) ANTIBODIES IN ANTI-TNF-ALPHA ANTIBODY-TREATED PATIENTS WITH INFLAMMATORY BOWEL DISEASES (IBD)Publication without faculty affiliation
- Formation of antiphospholipid antibodies and antibodies to infliximab in anti-TNF-alpha antibody treated patients with inflammatory bowel diseasesPublication without faculty affiliation
- Detection of circulating tumor cells during follow-up of patients with early breast cancer: Clinical utility for monitoring of therapy efficacy2014 | First Faculty of Medicine
- Identification of Rice Proteins Recognized by the IgE Antibodies of Patients with Food Allergies2013 | First Faculty of Medicine, Faculty of Science
- Phosphatidylserine-dependent anti-prothrombin antibodies (aPS/PT) in infliximab-treated patients with inflammatory bowel diseases2013 | First Faculty of Medicine
- Reference values of laboratory tests2013 | First Faculty of Medicine
- Low serum deoxyribonuclease I activity is associated with antiTNF-alpha induced skin adverse events in patients with inflammatory bowel disease2012 | First Faculty of Medicine
- Matrix metalloproteinases in serum and the follicular fluid of women treated by in vitro fertilization.2012 | First Faculty of Medicine
- Influence of albuminemia on the pharmacokinetics of infliximab in patients with inflammatory bowel diseases2011 | First Faculty of Medicine
- Impaired Deoxyribonuclease I Activity in Patients with Inflammatory Bowel Diseases2011 | First Faculty of Medicine
Loading network view...